Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Treatment and Referral Patterns for Colorectal Cancer

Bibliographic Data

ID9104807
AuthorsSusan A Oliveria (Cornell University, corresponding author), Marianne Ulcickas Yood (0000-0003-4204-0871, Yale University), Ulka B Campbell (0000-0002-3503-8178, Columbia University, corresponding author), Steven M Yood (Yale New Haven Hospital), Paul Stang (0000-0002-9528-9657, University of North Carolina at Chapel Hill, corresponding author)
Year2004
Volume42
Issue9
Pages901-906
Publication date2004-09-01
Open AccessNo
TypeARTICLE
VenueMedical Care (JOURNAL)
Journal identifiersISSN: 0025-7079 • E-ISSN: 1537-1948
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/01.mlr.0000135820.44720.89
PMID15319616
OpenAlexW2023962984
LanguageEN
Citations received1
References cited31

BACKGROUND: National guidelines recommend adjuvant chemotherapy for colorectal cancer stages III, and IV; however, it has been shown that only 45-55% of these patients receive chemotherapy. OBJECTIVES: We sought to describe treatment patterns for patients diagnosed with colorectal cancer and to examine the reasons why patients do not receive chemotherapy. RESEARCH DESIGN: This was a retrospective cohort study. SETTING AND PATIENTS: Patients included newly diagnosed cases of colorectal cancer at a health maintenance organization in central Massachusetts between January 1, 1997, and June 30, 1999. MAIN OUTCOME MEASURE: The main outcome measure was a referral or visit to an oncologist. RESULTS: Sixty-six percent (n=143) of the 217 colorectal cancer cases had a referral/visit to an oncologist or evidence of chemotherapy within 4 months of the index date. The referral rates by stage were: stage I, 47.7%; stage II, 59.5%; stage III, 87.1%; and stage IV, 66.7%. Of patients not referred with stage III disease, 4/8 were not referred because the treating physician did not recommend an oncology referral; patient refusal accounted for 3/8 (37.5%). The most commonly cited reason for lack of referral for stage IV patients was existing comorbidities or death. Younger age (<70 years) and stage III at diagnosis were significant predictors of oncology referral/visit. CONCLUSIONS: A substantial proportion of colorectal cancer patients are receiving appropriate referral for chemotherapy. This study is the first to elucidate reasons why patients do not receive chemotherapy and highlights both patient and physician factors

Cancer · Chemotherapy · Colorectal cancer · Disease · Family medicine · Referral · Retrospective cohort study · Stage (stratigraphy) · Colorectal Cancer Screening and Detection · Colorectal Cancer Treatments and Studies · Global Cancer Incidence and Screening · Internal Medicine · Medicine

  • Trends in Disparities in Receipt of Adjuvant Therapy for Elderly Stage III Colon Cancer Patients

    Amy J Davidoff, Thomas Rapp et al.•Medical Care•2009

  • Racial Differences in the Treatment of Early-Stage Lung Cancer

    Peter B Bach, Laura D Cramer et al.•New England Journal of Medicine•1999

Citations per year0.06
Citation span2009 - 2009 (1)
Highly citedNo

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae